There is much to suggest that certain of the biologic effects of endotoxins of Gram-negative bacteria are consequences of a reaction involving blood platelets. Thromhocytopenia occurring after injection of endotoxin is well documented (1, 2) and is associated with the appearance of platelet aggregates in pulmonary arterial blood (3). Concomitantly 5-hydroxytryptamine (5HT), which normally circulates virtually completely bound to platelets in an inactive form, appears in plasma in appreciable quantities (4-6). These observations suggest that the interaction of endotoxin and platelets in vivo results in platelet aggregation, trapping of these aggregates in vascular beds, and a transfer of pharmacologically active platelet factors, including 5HT, from platelets to plasma. The studies to be reported herein indicate that platelet aggregation and transfer of 5HT from platelets to plasma can also be observed in vitro during the course of incubation of platelet-rich rabbit plasma with endotoxin. In addition, two other platelet factors, platelet phospholipid and a heat-stabile bactericidin active against Bacillus subtilis, are liberated from platelets during incubation with endotoxin.
There is much to suggest that certain of the biologic effects of endotoxins of Gram-negative bacteria are consequences of a reaction involving blood platelets. Thromhocytopenia occurring after injection of endotoxin is well documented (1, 2) and is associated with the appearance of platelet aggregates in pulmonary arterial blood (3). Concomitantly 5-hydroxytryptamine (5HT), which normally circulates virtually completely bound to platelets in an inactive form, appears in plasma in appreciable quantities (4) (5) (6) . These observations suggest that the interaction of endotoxin and platelets in vivo results in platelet aggregation, trapping of these aggregates in vascular beds, and a transfer of pharmacologically active platelet factors, including 5HT, from platelets to plasma. The studies to be reported herein indicate that platelet aggregation and transfer of 5HT from platelets to plasma can also be observed in vitro during the course of incubation of platelet-rich rabbit plasma with endotoxin. In addition, two other platelet factors, platelet phospholipid and a heat-stabile bactericidin active against Bacillus subtilis, are liberated from platelets during incubation with endotoxin.
Materials and Methods
All glassware was freshly siliconized by immersion in a 1:1000 dilution of Dow Coming Z4141 for 1 hour and was baked for 2 hours at 170°C prior to use. An Escher~hia coli endotoxin of the Boivin type (Difco E. coli endotoxin lot 0127:B8) suspended in saline solution to a concentration of 2 mg per ml was used in all experiments. Several preparations bearing different control numbers of this lot of endotoxin were used and were found to vary somewhat in activity.
Preparation of Plasma.--Rabbit blood was obtained from a freely bleeding marginal ear vein or by cardiac puncture and delivered directly into siliconized tubes containing anticoagulant. Except as specifically indicated the anticoagulant used was sodium citrate in a final concentration of 0.38 per cent. Heparin in a final concentration of 1 per cent or disodinm ethylenediaminetetraacetate (EDTA) in a final concentration of 0.2 per cent was used in certain experiments. Platelet-rich plasma (PRP) was prepared by centrifugation of anticoagulated whole blood in a 15 ml graduated centrifuge tube at 1000 m,~r (225 g at the bottom of the tube) for 20 to 30 minutes at 4oC in a refrigerated centrifuge (International, model 2, with an 8 place head, catalog No. 269, and 50 ml cups, catalog No. 320). The superuatant plasma from citrated or EDTA blood contained from 400,000 to 800,000 platelets per c. mm and negligible numbers of white and red cells. PRP prepared from heparinized blood contained substantially fewer platelets, apparently because of increased tendency to spontaneous platelet clumping. The total 5HT content of PRP was determined after lysis of the platelets by three cycles of freezing and thawing. Centrifugation of PRP at 3000 I~PM (2000 g at the bottom of the tube) for 30 minutes yielded platelet-poor plasma which contained only small amounts of 5HT, usually less than 50 NG per ml. 5HIT content of the platelet residue, determined after resuspension of the platelets in a volume of saline equal to that of the plasma from which they had been sedimented and lysis of the suspension by freezing and thawing, ranged from 6,000 to 18,000 NG per ml. Mixtures of PRP and endotoxin were incubated at 37°C in a standard bacteriology incubator, and during incubation were constantly rotated at 15 lZP~ on a motor-driven Spinnerette (model ST, New Brunswick Scientific Co., New Brunswick, New Jersey).
Measurement oJ Available Platdel Phospkolipid (Product I Substrate Time).--The amount
of platelet phospholipid available to the clotting process was determined by adding preformed product I and calcium to the test plasma and determining the dotting time of this mixture (product I substrate time) (12) . Stable product I was prepared from rabbit instead of human blood reagents according to the method of Spaet (13) . The clotting system consisted of 0.1 ml of a dilution of stable product I, 0.1 ml 0.025 ~x CaCh, and 0.1 ml of test plasma in the. platelet-rich state. The dilution of product I was adjusted to give a minimal product I substrate time of 10 seconds or less when tested with plasma in which cephalin in optimum concentrations substituted for platelet phospholipid (14) . This dilution was usually 1:10 or 1:20. 
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TExT-Fzo. 1. Concentration of 5HT in plasma (broken line) or platelets (solid line) during incubation of 100 gg per ml of E. coli endotoxin (ll) or saline (O) with platelet-rich rabbit plasma.
When cephalln plasma was serially diluted in platelet-poor plasma, a straight fine log-log plot relating product I substrate time to phospholipid concentration was obtained indicating that the test assayed available pbospholipid.
Measurement of Bactericidal Activity of Plasma.--Plasma bactericidal activity against B. subtilis was determined by a modification of the method of Hirsch (15) . Test plasma specimens were first centrifuged to remove platelets and then serially diluted in twofold steps in 0.5 ml sterile physiological saline solution containing 0.05 per cent bovine albumin (Armour Laboratories, Chicago, Illinois). An 18 hour growth of B. subtilis on trypticase-soy agar was suspended in physiological saline solution containing 0.05 per cent bovine albumin and turbidometrically standardized to contain approximately 2000 viable units per nil. Each dilution of test plasma (0.5 ml) was mixed with 0.5 ml of bacterial suspension and incubated for 1 hour at 37°C. A mixture of equal parts of bacterial suspension and saline-aibumin diluent served as a control Pour plates were then prepared with 0.1 ml aiiquots of the plasma-B.
subtilis mixture and melted trypticase-soy agar. Colonies were counted after 24 hours' incubation, and the titer of bactericidal activity was expressed as the reciprocal of the highest dilu-tion of plasma which effected a 50 per cent or greater reduction in bacterial count as compared with control plates.
EXPERIMENTAL

Rdease of 5HT during Incubation of Platelets with Endotoxin.--Repeated
experiments have demonstrated that incubation of citrated rabbit PRP with endotoxin is associated with a progressive transfer of 5HT from platelets to plasma. 
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1,000 * 0 to ++++ indicates degree of platelet aggregation.
Endotoxin was added to rabbit PRP to a final concentration of 100 #g per ml of plasma and a second portion of the same PRP was inoculated with a similar volume of saline. Both mixtures were rotated in an incubator at 37°C. Aliquots of each were removed at intervals, centrifuged to sediment platelets, and 5 HT concentrations of the plasma supernate and platelet residue determined.
As is shown in Text- fig. 1 , in the specimen of PRP to which saline had been added only a small transfer of 5HT from platelets to plasma occurred. In contrast, in the specimen containing endotoxin a marked transfer was seen as shown by a progressive increase in plasma 5HT content and a reciprocal decrease in the concentration of 5HT in the platelet residue. In many instances this transfer was nearly complete after 3 hours' incubation.
Changes in Platelet Morphology
Induced by Endotoxin.--PRP which had been incubated with endotoxin appeared less opalescent in the gross than control PRP incubated with saline, and microscopic observations confirmed the notion that platelet aggregation accounted for this clearing. Phase microscopic inspection of control preparations (Fig. 1A) revealed intact evenly dispersed platelets. However, in the endotoxin-PRP mixtures (Fig. 1B) a process of aggregation and fusion of platelets had occurred to a degree roughly parallel to the release of 5HT. Aggregation and fusion of platelets could be differentiated with considerable confidence from simple clumping in which individual cells remained distinguishable. These morphologic changes are similar to those termed viscous metamorphosis by others (16) . Release of Platelet 5HT.--The interaction of endotoxin and PRP is dosedependent and is strikingly influenced by the type of anticoagulant.
Influence of Concentration of Endotoxin and Type of Anticoagulant on the
E. coli endotoxin in graded doses of 100, 10, and 1 #g per ml was added to PRP prepared with citrate, heparin, or EDTA. Control flasks of PRP were treated with similar volumes of saline solution. At intervals varying from 90 to 180 minutes in different experiments the specimens were centrifuged to remove platelets and concentrations of 5HT in the supernatant plasmas determined. The proportion of 5HT released to total 5HT was determined by measuring the 5HT concentration remaining in the platelet residue or the total 5HT content in an aliquot of untreated PRP. Table I , endotoxin in a concentration of 1 or 10/~g per ml caused almost no platelet aggregation or release of 5HT in citrated PRP, whereas endotoxin in a concentration of 100/~g per ml evoked a nearly complete release of 5HT and marked platelet aggregation. In other experiments the intermediate dose of endotox/n (10/~g per ml) demonstrated slight activity but always substantially less than the larger dose. Table II illustrates the effects of incubation of endotoxin with heparinized PRP. Platelets in heparinized plasma exhibit spontaneous platelet aggregation not found in either sodium citrate or EDTA plasma, and heparinized PRP contained substantially lower numbers of platelets and total 5HT. Nevertheless, platelet aggregation and a substantial transfer of 5HT from platelets to plasma occurred at endotoxin concentrations of 1 ~g per ml (61 per cent of platelet 5HT transferred to plasma) or 10/zg per ml (77 per cent of platelet * Saline, 0.1 ml per ml of PRP. E. coli endotoxin, 100/zg per ml PRP. § 0 to +q--F+ indicates degree of platelet aggregation.
As is illustrated in
5HT transferred to plasma) of heparinized PRP. As noted in the preceding paragraph, 10 #g of endotoxin caused only slight platelet aggregation or release of 5HT in citrated PRP.
When EDTA was used as an anticoagulant, no morphologic change or 5HT release could be demonstrated at any of the three endotoxin concentrations tested.
Effect of Temperature on the Endotoxin-Platelet Interaction.--
Citrated PRP was divided into four aUquots, two of which were inoculated with endotoxin, 100 pg per ml, and two with saline solution. One endotoxin-containing and one saline-containing aliquot were slowly rotated at 37°C and the other two specimens were rotated at 4°C. Specimens were removed at intervals and concentrations of plasma 5HT determined after separation of plasma and platelets by centrifugation.
As is seen in Table III , platelet aggregation and release of platelet 5HT occurred when endotoxin was incubated with PRP at 37°C, whereas neither morphologic change nor release of 5HT occurred when the reaction was carried out at 4°C. The spontaneous platelet aggregation observed by others (17) to occur at 4oc did not interfere with these microscopic observations which were made after the slides had remained several minutes at room temperature.
Other Substances Active in Releasing 5HT from Platelets.--Heat-killed E. coli in concentration of l0 s cells per ml of PRP was found to be quite active in releasing platelet 5HT. Similar activity was demonstrated by equal concentrations of heat-killed staphylococci, pneumococci, and streptococci, but polysterene latex particles of coccal size were without effect. Platelet aggregation and release of 5HT as described by others (18) (19) (20) in the presence of antigen-antibody reactions could also be observed in the system used in these experiments. These changes were observed after addition of human gamma globulin and rabbit anti-human gamma globulin to a nonimmunized animal's plasma or after addition of human gamma globulin to PRP obtained from an animal immunized with human gamma globulin.
Evidence for the Participation of Plasma Factors in the Interaction of Platelets and Endotoxin.--
Three aliquots of PRP were centrifuged and the sedimented platelets set aside. Two of the plasma supernates were heated at 56°C for 30 minutes, and the third was kept at room temperature. After the heated specimens had returned to room temperature, the platelets were resuspended in the plasmas from which they had been removed. Endotoxin in a concentration of 100 #g per ml was added to one of the suspensions of platelets in previously heated plasma, and to the platelets suspended in plasma which had been kept at room temperature. As a control, saline was added to the rem,lnlng aliquot of platelets in previously heated plasma.
The three aliquots were then incubated at 37°C and samples were removed at intervals for determination of content of 5HT in plasma and platelets.
Heating plasma at 56°C for 30 minutes inactivates or removes some factor necessary for the endotoxin-platelet interaction. As shown in Table IV , endotoxin in a concentration of 100 #g per ml produced marked platelet aggregation and release of 5HT when incubated with platelets resuspended in unheated normal plasma, but had no apparent effect on platelets in plasma previously heated at 56°C for 30 minutes. The plasma factor that is removed or inactivated by heating at 56°C for 30 minutes is not restored by addition of fresh pooled guinea pig serum.
A lag period of 30 to 60 minutes has been consistently observed between addition of endotoxin to PRP and the occurrence of platelet aggregation and release of 5HT. This is illustrated in the experiment depicted in Text- fig. 2 in which observations were made every 15 minutes. Morphologic changes in platelets were not observed until 30 minutes after addition of endotoxin and appreciable amounts of plasma 5HT did not appear until 60 minutes after endotoxin had been added.
It is of interest that the lag period between addition of endotoxin and release of platelet 5HT could be shortened by incubation of endotoxin with plasma prior to addition of platelets.
Three aliquots of PRP were centrifuged and the sedimented platelets set aside. Endotoxin in a concentration of 100/~g per ml was added to the supernatant plasma from the first aliquot, saline solution was added to the second aliquot, and nothing was added to the third. The three aliquots of plasma were rotated at 37°C for 90 minutes. The platelets were then resuspended in the plasma aliquots from which they had been removed, and at this time 100/zg per ml of endotoxin was added to the third previously untreated aliquot. All specimens were again rotated at 37°C and samples removed at intervals, spun to remove platelets, and the supernatant plasma assayed for 5HT content.
When platelets and endotoxin were added to plasma which had been incubated at 37°C for 90 minutes, the usual lag period between addition of endotoxin and the appearance of platelet aggregation or release of platelet 5HT 3 . Time of appearance of platelet aggregation and release of 5HT (.4) after resuspension of platelets in plasma previously incubated with I00/zg per ml of E. coli endotoxin at 37°C for 90 minutes, (B) after addition of 100/zg per ml of E. coli endotoxin to platelets resuspended in plasma previously incubated at 37°C with 0.I ml saline per ml for 90 minutes, and (C) after resuspension of platelets in plasma previously incubated with saline solution. 0 to -i--{-~-b indicates degree of platelet aggregation.
was observed (Text-fig. 3 ). In contrast, the specimen of plasma previously incubated with endotoxin demonstrated moderate platelet aggregation and a high concentration of plasma 5HT as soon as 15 minutes after resuspension of platelets and maximum changes had occurred by 30 minutes. No change in plasma 5HT occurred in the saline control over the period of observation.
Platelet aggregation and release of 5HT induced by addition of N.. coli or staphylococci to rabbit PRP could be inhibited by prior absorption of plasma with bacterial cells.
Platelets were removed from four aliquots of PRP by centrifugation. Two aliquots of supematant plasma were incubated at 37°C for 90 minutes with thrice washed heat-killed E. coli in a concentration of l0 s cells per ml, and the other two aliquots were incubated with saline solution as controls. The plasmas were centrifuged to remove the bacterial cells, and the platelets then resuspended in their original plasmas. Heat-killed E. coli in a con-centration of l0 s cells was then added to one of the E. coli absorbed and one of the control specimens, and a similar concentration of heat-killed S. aureus was added to the other E. coli absorbed and the other control specimen. All four suspensions were then reincubated at 37°C for 90 minutes. Platelet morphology and plasma 5HT concentrations were determined immediately after the final addition of E. coli and again after 90 minutes' incubation.
Prior absorption of plasma with E. coli greatly diminished the response of resuspended platelets to subsequent chalenge with homologous or heterologous bacterial cells (Table V) . Plasma was absorbed with 10 a heat-killed E. coli per ml, 37°C for 90 minutes, centrifuged; platelets then resuspended in absorbed plasma.
Release of Plalelet Phospholipid during Incubation of PRP with Endotoxin.--
§ Plasma was mixed with 0.05 ml of saline solution per ml of plasma, incubated at 37°C for 90 minutes, centrifuged; platelets then resuspended in plasma.
[] 0 to ++++ indicates degree of platelet aggregation.
The intrinsic or blood coagulation process is classically represented in three stages, thromboplastin generation, conversion of prothrombin to thrombin, and conversion of fibrinogen to fibrin. Each successive stage is catalyzed in part by the product of the preceding one. When fully formed blood thromboplastin (21) is supplied and prothrombin and fibrinogen are present in normal amounts, the second and third stages proceed to completion in about 10 seconds or less. Any time beyond this period necessary for normal blood or plasma to coagulate is a measure of the time required for the first stage to proceed to completion under the experimental circumstances. The first stage is thought to involve two parallel processes which interact at their completion. On the one hand an interaction of several first stage factors forms a powerful coagulation activity termed product I (21), and on the other hand intact platelets make phospholipid available to the clotting process (22) . Blood thromboplastin results from the interaction of product I and available platelet phospholipid in the presence of factor V and calcium (21) .
McKay and associates (23) and Robbins and Stetson (17) have demonstrated that bacterial endotoxin shortens the coagulation time of recalcified citrated plasma or whole blood in siliconized tubes. This coagulation acceleration occurred only when platelets were present, and was necessarily a function of a shortened first stage. The acceleration of the first stage of coagulation induced by endotoxin could be mediated through an acceleration of product I formation, or through an effect on platelets to make phospholipid available. If the coagulation-accelerating effect of endotoxin should obtain when preformed product I 
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is supplied in excess, this would indicate that the acceleration is consequent to an effect on platelets which increases the availability of phospholipid for the clotting process.
PRP was incubated at 37°C with endotoxin in concentrations of 100 and 10 #g per ml. Aliquots were removed at intervals and assayed for product I substrate activity (available phospholipid) by determining the dotting time after addition of product I and calcium. Prodduct I substrate times were also determined on specimens of platelet-poor plasma containing brain cephalin as a phospholipid substitute during the course of incubation with endotoxin.
Addition of preformed product I and calcium to plasma in which added cephalin provided freely available phospholipid resulted in dotting in approximately 10 seconds, and incubation of the mixture of plasma and cephalin with endotoxin did not further accelerate coagulation after addition of product I and calcium (Table VI) . However, when product I and calcium were added to plasma in which intact platelets served as the only source of phospholipid, dotting was delayed approximately 20 seconds, this prolongation representing the time necessary for platelets to release phospholipid. The product I substrate time of PRP incubated with 10 or 100 #g per ml of g. coli endotoxin progressively decreased to an extent proportional to the duration of incubation, and by 60 minutes sufficient phospholipid had become available so that its concentration was no longer the rate-limiting factor. Participation of surfaceactivated factors seemed excluded by the finding that maximal surface activation (agitation of PRP with 25 per cent by volume Celite powder, Johns Manville) did not appreciably alter the product I substrate time.
Release of Platelet BacteHcidins during Incubation of PRP with Endotoxin.--Hirsch (15) and others (24) have presented evidence for a bactericidal system contained in platelets which is active against certain Gram-positive organisms, An aliquot of PRP was incubated with endotoxin, 100/zg per ml at 37°C. A control aliquot was incubated with saline solution. Samples of PRP were removed at zero, 90, and 180 minutes after incubation and centrifuged to remove platelets. The fiter of bactericidal activity against B. subtilis in the plasma supernate was determined by a serial dilution technique described under Methods.
No change in fiter of plasma bactericidal activity was observed in the salinetreated aliquots (Table VII) . However, in the aliquot of PRP incubated with endotoxin the bactericidal activity in the plasma supernate increased more than 16-fold and 5HT appeared in the plasma in increasing amounts. A decrease in bactericidal activity in the platelet residue occurred concomitantly with the increase in bactericidal activity of plasma. Additional experiments have shown that the endotoxin-induced release of B. subtilis bactericidins is also influenced by dose of endotoxin, temperature of incubation, and anti-coagulant, and is dependent on the presence of heat-labile plasma factors in a manner quite similar to that previously described for the release of 5HT.
DISCUSSION
A reaction between endotoxins of Gram-negative bacteria and platelets leading to platelet aggregation and release of platelet factors, as demonstrated by the in ~tro studies described in this report, may be of importance in the pathogenesis of certain biologic events observed in the intact host after injection of endotoxin.
Platelet aggregates have been detected in the circulating blood of rabbits inoculated intravenously with endotoxin (3), and it is reasonable to postulate that these aggregates as well as altered individual platelets are trapped in small blood vessels in vascular beds. The characteristic granulocytopenia observed after injection of endotoxin has been attributed to sequestration of white cells within pulmonary blood vessels and spleen (1, 25) , and it is likely that the mechanism of thrombocytopenia has many similarities. Platelet and leukocyte thrombi in small blood vessels have been observed after single injections of endotoxin, and are among the most prominent pathological findings in the local and generalized Shwartzman phenomena, occurring prior to overt vascular rupture (25) .
The transfer of 5HT from platelets to plasma during incubation of plateletorich plasma with endotoxin in ~tro closely parallels the extent of platclet aggregation. As mentioned previously, Davis, Meeker, and McQuarrie (3) have presented evidence that platelet aggregates appear in circulating blood of dogs after injection of endotoxin. Other studies (4) (5) have clearly shown that increases in plasma 5HT concentrations also occur following endotoxin injections in dogs and rabbits. Although the increase in plasma 5HT concentration is small and transient, the concomitant fall in whole blood 5HT content is much more extensive, at times exceeding 80 per cent of control whole blood 5HT values (6) . This decrease in whole blood 5HT is probably due both to transfer of 5HT from platelets to plasma with subsequent rapid enzymatic degradation, and to removal of platclet-bound 5HT as the sequestration of platelets develops.
Thomas and associates (26) , as part of an extended investigation of the mechanisms underlying the Shwartzman phenomena, have demonstrated that both 5HT and endotoxin greatly enhance the necrotizing and vasomotor effects of epinephrine and norepinephrine on small blood vessels. These observations led to the hypothesis that part of the effect of endotoxin may be to make 5HT available in or around the walls of blood vessels for an action in concert with epinephrine. Although speculative, this idea blends well with the evidence that endotox~-platelet interactions in ~tro and i~ ~ro result in release of 5HT, and also with the protective action of antiserotonin compounds against the lethal effects of endotoxin (27) .
A recent review by Gilbert (28) has compiled a large body of experimental evidence indicating that profound vasomotor changes and injury to the microclrculation occur after injection of bacterial endotoxin. These changes are rapid in onset, and include vasoconstriction followed by vasodilatation, profound systemic hypotension, and in-crease in portal and pulmonary vascular resistance and organ weight in certain species. Hinshaw and associates (29) , in studying the effects of endotoxin on the isolated perfused dog lung, noted that the increase in organ weight and vascular resistance which occurred when endotoxin was perfused in whole blood or cell-rich plasma did not obtain when the endotoxin-containing perfusate was cell-poor plasma, dextran, or gelatin. Since 5HT itself causes entirely similar changes in pulmonary vascular resistance and lung weight (30) (31) (32) , it seems possible that the substance in blood or cellrich plasma necessary/or this activity of endotoxin may be platelet 5HT.
The prominence of platelet-leukocyte thrombi in the local and generalized Shwartzman phenomena and their occurrence after single injections of endotoxin (25) have led several investigators to study endotoxin-induced changes in the coagulation system. Among these, McKay and associates (23, 25) and Robbins and Stetson (17) demonstrated that in viva injections of endotoxin and in vitro incubation of whole blood or plasma with endotoxin were followed by shortening of the coagulation time as measured in siliconized tubes. These in vitro changes occurred only when platelets were present, and are compatible with the concept that the endotoxin effect was mediated by release of platelet phospholipid, as demonstrated in the present studies. In this regard, Spaet (33) has demonstrated that intravenous injection of crude phospholipid in rabbits causes a transient but marked hypercoagulable state. This systemic change might be of great local importance if vascular injury, vasospasm, and platelet aggregates are also present to favor the development of intravascular thrombosis.
The rather constant lag period between addition of endotoxin and release of 5HT from platelet-rich plasma in vitro is discordant with the immediate changes in plasma and whole blood 5HT following endotoxin injections in vivo. This disparity may be more apparent than real, since all the anticoagulants used in in vitro studies inhibit platelet changes to one degree or another. Moreover, in the in vivo systems it is likely that initial platelet changes result in the appearance of thrombin which itself is an extremely active promoter of platelet viscous metamorphosis and might lead to an autocatalytically accelerated reaction.
The findings presented herein are compatible with the concept that the effect of endotoxin on platelets involves immune mechanisms. Antigen-antibody reactions have been demonstrated to produce platelet aggregation, release of histamine, and release of 5HT in vitro (18, 19) . Two groups (20, 19, 34) have reported that injections.of antigen in sensitized animals are followed by changes in whole blood and plasma 5HT content entirely similar in magnitude and time of onset to those observed after injection of endotoxin. Two recent studies of the action of antigen-antibody reactions on platelets have been reported, one (35) measuring platelet aggregation and the other (36, 37) release of platelet histamine. Both of these studies presented evidence that plasma factors were necessary, but differed as to whether these factors were components of complement or represented an analogous but separate lyric system. The present studies do not allow a decision as to whether the plasma factor involved is complement. Heating plasma at 56°C for 30 minutes resulted in loss of this plasma activity and addition of guinea pig complement did not restore it. However, fibrinogen is precipitated by heating at 56°C for 30 minutes, and Jackson has presented evidence that fibrinogen is necessary for thrombininduced platelet aggregation (38) .
SUMMARY
Incubation of platelet-rich rabbit plasma with E. coli endotoxin at 37°C results in platelet aggregation and transfer of platelet 5-hydroxytryptamine to plasma. Release of 5HT is influenced by dose of endotoxin, type of anticoagulant, and temperature of incubation. A heat-labile plasma factor is necessary for the platelet-endotoxin interaction. Additional studies have shown that incubation of endotoxin with platelet-rich rabbit plasma also results in release of platelet phospholipid and bactericidins active against B. subtilis. 
